Brief: Orexo Q1 EBITDA Swings To Loss Of SEK 23.9 Mln
April 29 (Reuters) - Orexo AB ORX.ST :
* OREXO Q1 2021 INTERIM REPORT
* Q1 TOTAL NET REVENUES OF SEK 132.3 M (175.0)
* Q1 EBITDA OF SEK -23.9 M (39.1)
* ZUBSOLV® DEMAND HAS STABILIZED COMPARED TO PREVIOUS
QUARTER,
Source text for Eikon: ID:nWkr3sHLQl
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens